Skip to main content
VMD
NASDAQ Life Sciences

Viemed Healthcare Reports Q1 Revenue of $75.4M, Net Income $2.7M

Reported by Reuters
Sentiment info
Neutral
Importance info
8
Price
$9.62
Mkt Cap
$373.291M
52W Low
$5.93
52W High
$10.18
Market data snapshot near publication time

Summary

Viemed Healthcare has released its first-quarter 2026 financial results, reporting revenue of $75.414 million and net income of $2.713 million. The company also posted an income from operations of $4.296 million and a gross profit of $42.827 million. These figures provide the initial financial performance update for the current fiscal year, following the strong 2025 results. Professional traders will closely scrutinize these core metrics to assess the company's current operational health and growth trajectory against market expectations. The focus will now shift to the upcoming earnings call for management's commentary on these results and any updated full-year guidance.

At the time of this announcement, VMD was trading at $9.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $373.3M. The 52-week trading range was $5.93 to $10.18. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

VMD - Latest Insights

VMD
May 05, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
VMD
May 05, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
VMD
Apr 22, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
VMD
Mar 20, 2026, 5:06 PM EDT
Filing Type: 4
Importance Score:
8
VMD
Mar 20, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
VMD
Mar 19, 2026, 4:11 PM EDT
Filing Type: 144
Importance Score:
7
VMD
Mar 16, 2026, 4:51 PM EDT
Filing Type: 8-K
Importance Score:
7
VMD
Mar 04, 2026, 4:50 PM EST
Filing Type: 10-K
Importance Score:
8
VMD
Mar 04, 2026, 4:45 PM EST
Source: Reuters
Importance Score:
7
VMD
Feb 02, 2026, 5:35 PM EST
Filing Type: 4
Importance Score:
8